Immune response genes in uveitis

Ocular Immunology and Inflammation

Volumn 17, Issue 4, 2009, Pages 249-256

  Du, Liping ^a   Kijlstra, Aize ^b   Yang, Peizeng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HLA; Immune response; Nucleotide binding oligomerization domains; Toll like receptors; Uveitis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA A29 ANTIGEN; HLA ANTIGEN; HLA B27 ANTIGEN; HLA B51 ANTIGEN; HLA DR15 ANTIGEN; HLA DR4 ANTIGEN; INTERLEUKIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MANNOSE BINDING LECTIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SUMO 4 PROTEIN; SUMO PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; BEHCET DISEASE; CASPASE RECRUITMENT DOMAIN 4 GENE; CASPASE RECRUITMENT DOMAIN 5 GENE; CHORIORETINOPATHY; DNA POLYMORPHISM; GENE MUTATION; GENETIC SUSCEPTIBILITY; HISTOCOMPATIBILITY GENE; HLA SYSTEM; HUMAN; IMMUNE RESPONSE GENE; INNATE IMMUNITY; INTERLEUKIN 1 GENE; INTERMEDIATE UVEITIS; IRIDOCYCLITIS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SYMPATHETIC OPHTHALMIA; TOLL LIKE RECEPTOR GENE; TUMOR NECROSIS FACTOR GENE; UVEITIS; VOGT KOYANAGI SYNDROME;

CHEMOKINES; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; IMMUNITY, INNATE; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; TOLL-LIKE RECEPTORS; UVEITIS;

EID: 68849090970     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940902999356     Document Type: Review

References (73)

1. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216.
2. Sohn JH, Kaplan HJ, Suk HJ, et al. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci. 2000;41:3492-3502.
3. Sohn JH, Kaplan HJ, Suk HJ, et al. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest Ophthalmol Vis Sci. 2000;41:4195-4202.
4. Jha P, Bora PS, Bora NS. The role of complement system in ocular diseases including uveitis andmacular degeneration. Mol Immunol. 2007;44:3901-3908. (Pubitemid 47337119)
5. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J ExpMed. 1994;180:2359-2364.
6. Wakefield D, Montanaro A, McCluskey P. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 1991;36:223-232.
7. Rosenbaum JT, Rosenzweig HL, Smith JR, et al. Uveitis secondary to bacterial products. Ophthalmic Res. 2008;40:165-168.
8. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003;21:335-376.
9. Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol. 2006;90:103-108. (Pubitemid 43029907)
10. Dabbagh K, Lewis DB. Toll-like receptors and T-helper-1/Thelper- 2 responses. Curr Opin Infect Dis. 2003;16:199-204.
11. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science. 1996;272:50-53.
12. Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 1997;388:394-397. (Pubitemid 27334820)
13. Brito BE, Zamora DO, Bonnah RA, et al. Toll-like receptor 4 and CD14 expression in human ciliary body and TLR-4 in human iris endothelial cells. Exp Eye Res. 2004;79:203-208.
14. Chang JH, Hampartzoumian T, Everett B, et al. Changes in Tolllike receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis. Invest Ophthalmol Vis Sci. 2007;48:1711-1717. (Pubitemid 351261357)
15. Chang JH, McCluskey P, Wakefield D. Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. Invest Ophthalmol Vis Sci. 2004;45:1871-1878. (Pubitemid 38868984)
16. Fujimoto C, Shi G, Gery I. Microbial products trigger autoimmune ocular inflammation. Ophthalmic Res. 2008;40:193-199. (Pubitemid 351562902)
17. Inohara N, Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3:371-382. (Pubitemid 37323197)
18. Watanabe T, Kitani A, Murray PJ, et al. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol. 2004;5:800-808. (Pubitemid 39172973)
19. Strober W, Murray PJ, Kitani A, et al. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol. 2006;6:9-20. (Pubitemid 43279749)
20. Netea MG, Ferwerda G, de Jong DJ, et al. Nucleotide-binding oligomerization domain-2modulates specific TLR pathways for the induction of cytokine release. J Immunol. 2005;174:6518-6523. (Pubitemid 40663847)
21. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19-20.
22. Davey MP, Martin TM, Planck SR, et al. Human endothelial cells expressNOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide. Microvasc Res. 2006;71:103-107.
23. Rosenzweig HL, Martin TM, Jann MM, et al. NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis. Invest Ophthalmol Vis Sci. 2008;49:1518-1524.
24. Rosenzweig HL, Galster KT, Planck SR, et al. NOD1 is expressed in the eye and functionally contributes to IL-1beta dependent ocular inflammation in mice. Invest Ophthalmol Vis Sci. 2009;50:1746-1753.
25. Brewerton DA, Caffrey M, Nicholls A, et al. Letter: Acute anterior uveitis and HL-A 27. Lancet. 1974;1:464.
26. Schwimmbeck PL, Yu DT, Oldstone MB. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome: molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J ExpMed. 1987;166:173-181.
27. Linssen A, Rothova A, Valkenburg HA, et al. The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci. 1991;32:2568-2578.
28. Davey MP, Rosenbaum JT. The human leukocyte antigen complex and chronic ocular inflammatory disorders. Am J Ophthalmol. 2000;129:235-243. (Pubitemid 30089284)
29. Levinson RD. Immunogenetics of ocular inflammatory disease. Tissue Antigens. 2007;69:105-112.
30. Yabuki K, Inoko H, Ohno S. HLA testing in patientswith uveitis. Int Ophthalmol Clin. 2000;40:19-35.
31. Shah KH, Levinson RD, Yu F, et al. Birdshot chorioretinopathy. Surv Ophthalmol. 2005;50:519-541.
32. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50:364-388.
33. Byrom NA, Brown JJ, Davies DL, et al. T and B lymphocytes in patients with acute anterior uveitis and ankylosing spondylitis, and in their household contacts. Lancet. 1979;2:601-603.
34. Hou S, Yang P, Du L, et al. SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease. Clin Immunol. 2008;129:170-175.
35. Al-Mutawa SA, Hegab SM. Behcet's disease. Clin Exp Med. 2004;4:103-131.
36. Mizuki N, OtaM, Yabuki K, et al. Localization of the pathogenic gene of Behcet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41:3702-3708. (Pubitemid 30816151)
37. Islam SM, Numaga J, Fujino Y, et al. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 1994;35:3890-3896. (Pubitemid 24334547)
38. Alaez C, del PilarMoraM, Arellanes L, et al. Strong association of HLA class II sequences in Mexicans with Vogt-Koyanagi- Harada's disease. Hum Immunol. 1999;60:875-882. (Pubitemid 29476777)
39. Oruc S, Duffy BF, Mohanakumar T, et al. The association ofHLA class II with pars planitis. Am J Ophthalmol. 2001;131:657-659. (Pubitemid 32422128)
40. Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology. 1999;106:594-599.
41. Kilmartin DJ, Wilson D, Liversidge J, et al. Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol. 2001;85:281-286. (Pubitemid 32250755)
42. Levinson RD, Park MS, Rikkers SM, et al. Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci. 2003;44:653-657.
43. Du L, Yang P, Hou S, et al. Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome. Clin Immunol. 2008;127:43-48.
44. Ueda H, Howson JM, Esposito L, et al. Association of the Tcell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423:506-511. (Pubitemid 36648570)
45. Bye L, Modi N, StanfordMR, et al. CTLA-4 polymorphisms are not associated with ocular inflammatory disease. Tissue Antigens. 2008;72:49-53. (Pubitemid 351841648)
46. Verity DH, Wallace GR, Vaughan RW, et al. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behcet's disease. Tissue Antigens. 1999;54:264-272.
47. Lee EB, Kim JY, Lee YJ, et al. TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. Hum Immunol. 2003;64:614-620. (Pubitemid 36706054)
48. Duymaz-Tozkir J, GulA, Uyar FA, et al. Tumour necrosis factoralpha gene promoter region -308 and -376 G->A polymorphisms in Behcet's disease. Clin Exp Rheumatol. 2003;21:S15-S18. (Pubitemid 37193091)
49. Ahmad T, Wallace GR, James T, et al. Mapping the HLA association in Behcet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum. 2003;48:807-813. (Pubitemid 36302019)
50. Espinosa G, Arostegui JI, Plaza S, et al. Behcet's disease and hereditary periodic fever syndromes: casual association or causal relationship? Clin Exp Rheumatol. 2005;23:S64-S66.
51. Akman A, Sallakci N, Coskun M, et al. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behcet's disease. Br J Dermatol. 2006;155:350-356. (Pubitemid 44050569)
52. Park K, Kim N, Nam J, et al. Association of TNFA promoter region haplotype in Behcet's Disease. J Korean Med Sci. 2006;21:596-601. (Pubitemid 44199310)
53. Kamoun M, Chelbi H, Houman MH, et al. Tumor necrosis factor gene polymorphisms in Tunisian patientswith Behcet's disease. Hum Immunol. 2007;68:201-205. (Pubitemid 46356652)
54. Seki N, Yamaguchi K, Yamada A, et al. Polymorphism of the 5'- flanking region of the tumor necrosis factor (TNF)-alpha gene and susceptibility to human T-cell lymphotropic virus type I (HTLV-I) uveitis. J Infect Dis. 1999;180:880-883. (Pubitemid 29411383)
55. Kuo NW, Lympany PA, Menezo V, et al. TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci. 2005;46:1565-1571. (Pubitemid 44843587)
56. McGarry F, Walker R, Sturrock R, et al. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLAB27. J Rheumatol. 1999;26:1110-1116. (Pubitemid 29215076)
57. Gonzalez S, Torre-Alonso JC, Martinez-Borra J, et al. TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients. J Rheumatol. 2001;28:1288-1293. (Pubitemid 32510500)
58. Mizuki N, OtaM, KimuraM, et al. Triplet repeat polymorphism in the transmembrane region of theMICA gene: a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci U S A. 1997;94:1298-1303. (Pubitemid 27087845)
59. Goto K, Ota M, Ando H, et al. MICA gene polymorphisms and HLA-B27 subtypes in Japanese patients with HLA-B27- associated acute anterior uveitis. Invest Ophthalmol Vis Sci. 1998;39:634-637. (Pubitemid 28110698)
60. Ota M, Mizuki N, Katsuyama Y, et al. The critical region for Behcet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet. 1999;64:1406-1410. (Pubitemid 30468760)
61. Wallace GR, Verity DH, Delamaine LJ, et al. MIC-A allele pro- files and HLA class I associations in Behcet's disease. Immunogenetics. 1999;49:613-617.
62. Karasneh J, Hajeer AH, Barrett J, et al. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease. Rheumatology (Oxford). 2003;42:860-864. (Pubitemid 37220935)
63. Akman A, Ekinci NC, Kacaroglu H, et al. Relationship between periodontal findings and specific polymorphisms of interleukin- 1alpha and -1beta in Turkish patientswith Behcet's disease. Arch Dermatol Res. 2008;300:19-26. (Pubitemid 350231461)
64. Cordeiro CA, Moreira PR, Costa GC, et al. Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol Vis. 2008;14:1845-1849.
65. Menezo V, Bond SK, Towler HM, et al. Cytokine gene polymorphisms involved in chronicity and complications of anterior uveitis. Cytokine. 2006;35:200-206. (Pubitemid 44696305)
66. Chen Y, Vaughan RW, Kondeatis E, et al. Chemokine gene polymorphisms associatewith gender in patientswith uveitis. Tissue Antigens. 2004;63:41-45. (Pubitemid 38130441)
67. Wegscheider BJ, Weger M, Renner W, et al. Role of the CCL2/MCP-1 -2518A>G gene polymorphism in HLA-B27 associated uveitis. Mol Vis. 2005;11:896-900. (Pubitemid 41631824)
68. Yeo TK, Ahad MA, Kuo NW, et al. Chemokine gene polymorphisms in idiopathic anterior uveitis. Cytokine. 2006;35:29-35. (Pubitemid 44485532)
69. Ahad MA, Missotten T, Abdallah A, et al. Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis. Mol Vis. 2007;13:388-396. (Pubitemid 46477707)
70. Lee EB, Kim JY, Zhao J, et al. Haplotype association of IL-8 gene with Behcet's disease. Tissue Antigens. 2007;69:128-132. (Pubitemid 46174866)
71. Inanc N, Mumcu G, Birtas E, et al. Serum mannose-binding lectin levels are decreased in Behcet's disease and associated with disease severity. J Rheumatol. 2005;32:287-291. (Pubitemid 40209127)
72. Park KS, Min K, Nam JH, et al. Association of HYPA haplotype in themannose-binding lectin gene-2 with Behcet's disease. Tissue Antigens. 2005;65:260-265. (Pubitemid 40342432)
73. Li K, Zhao M, Hou S, et al. Association between polymorphisms of FCRL3, a non-HLA gene, and Behcet's disease in a Chinese population with ophthalmic manifestations. Mol Vis. 2008;14:2136-2142.